x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

BiotechTV - News

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

science life sciences

All Episodes

00:15:24

AI x Bio Summit: Recursion's Chief R&D Officer & CCO...

BiotechTV - News ·

2025/07/24

She describes Recursion's work, and what the acquisition of Exscientia has brought to the company. Plus, how AI can not only help with drug design, but also safety and patient recruitment.

en-us

00:20:25

After receiving a CRL for its RP1 oncolytic...

BiotechTV - News ·

2025/07/23

CEO Sushil Patel walks us through the decisions behind the design of the IGNYTE phase 1/2 study and the ongoing IGNYTE-3 study, he gives Replimune's impression of how the review went since the BLA was filed last November, and he discusses what the CRL could mean for the future.

en-us

00:10:41

AI x Bio Summit: The CEO of Alto Neuroscience, which...

BiotechTV - News ·

2025/07/23

Amit Etkin says Alto Neuro is trying to use machine learning to understand signals from the complexity of the brain, and the company is also embedding AI in its clinical trials in order to collect as much information from the field as possible. He also walks us through the company's program.

en-us

00:10:06

NYSE Strategist Eric Criscuolo shares his take on the...

BiotechTV - News ·

2025/07/23

He discusses the importance of interest rates to high risk sectors like biotech, and comment on how our sector has not performed lately like other "risk-on" assets have. Plus, explaining his job of helping CEOs of NYSE listed companies understand the economic and capital markets environment.Note: The NYSE is a sponsor of BiotechTV

en-us

00:12:47

AI x Bio Summit: The Co-Founder and Head of Machine...

BiotechTV - News ·

2025/07/22

Sam Sinai talks about how capsids are being more precisely designed today, which is allowing drug developers to better target them to different organs and to improve their efficiency. Plus, why he believes AI will help make cell and gene therapies reach more patients in the future.

en-us

00:10:08

RBC's Healthcare Desk Strategist Chris McCarthy...

BiotechTV - News ·

2025/07/22

He highlights recent M&A, but also notes how the sector has not been reliant on deals like it has in the past. Plus, discussing how Sarepta's wild ride has not led to contagion, and previewing what key data events are upcoming.

en-us

00:11:10

AI x Bio Summit: Nimbus Therapeutics' new CEO and...

BiotechTV - News ·

2025/07/22

CEO Abbas Kazimi and President of R&D Peter Tummino discuss how AI integrates into their discovery and clinical development work, and walk us through some of the company's current programs.

en-us

00:17:46

Metsera CEO Whit Bernard shares an update on the...

BiotechTV - News ·

2025/07/22

He describes data that Mestera presented at ADA for its monthly-dosed GLP1 and also its amylin analog. Plus, recent learnings about the field in general, including what orforglipron might mean for the oral therapy space and why Metsera believes in an oral peptide.

en-us

00:11:39

Cambridge, MA based Avalyn Pharma is developing a...

BiotechTV - News ·

2025/07/22

CEO Lyn Baranowski describes the therapy and demonstrates the nebulizer that delivers it, and explains how Avalyn's method is designed increase the dose patients can take vs oral therapies and, therefore, increase the therapeutic value.

en-us

00:09:00

On a visit through London today, NodThera's CEO Dan...

BiotechTV - News ·

2025/07/21

He discusses the science behind NLRP3, and describes why he thinks NodThera's brain penetration differentiates it from other programs from pharma and other companies. The weight loss program is a oral therapy that doesn't require titration and hasn't shown GI tolerability side effects.

en-us

00:25:11

Prime Medicine's new CEO Allan Reine walks us through...

BiotechTV - News ·

2025/07/17

He describes the benefits of prime editing, walks us through human proof-of-concept data that was announced in a patient with Chronic Granulomatous Disease, and explains the rationale to focus on Wilson's Disease, Alpha-1 Antitrypsin Deficiency, Cystic Fibrosis, and the company's CAR-T partnership with Bristol Myers Squibb.

en-us

00:30:39

Kailera Therapeutics' partner Hengrui announced...

BiotechTV - News ·

2025/07/16

He describes why Kailera chose to in-license a GLP1/GIP specifically, and describes where he sees this asset placing in the competitive landscape based on this data. Plus, commentary on CMC, business development, oral therapies, and more.

en-us

00:11:59

Southampton professor, and Curve Therapeutics' CSO,...

BiotechTV - News ·

2025/07/16

He describes the properties that make cyclic peptides unique compared to small molecules and antibodies, and how Curve's approach is different than others in the field. Plus, the work his team is doing on cyclic peptides in their lab at University of Southampton.

en-us

00:15:28

Southampton, UK based Curve Therapeutics believes its...

BiotechTV - News ·

2025/07/15

Co-Founder and CEO Simon Kerry discusses being in Southampton, and why he belives the 'Microcycle' platform beats screening in traditional well plates for discovery work. Curve currently has cash on hand to take at least one program into the clinic.

en-us

00:31:38

Checking in with MoonLake's CEO ahead of one of...

BiotechTV - News ·

2025/07/11

Jorge Santos da Silva walks us through the scientific design of the molecule, which is a nanobody that binds to IL-17A, IL-17F, and albumin. He compares and contrasts it to key competitor BIMZELX and describes what the company is hoping to see in the trial readout. Plus, commercial plans, pipeline, and more.

en-us

00:21:58

KalVista's CEO discusses today's FDA approval and...

BiotechTV - News ·

2025/07/07

Ben Palleiko is asked about the company's take on headlines that were in the news during the FDA review of the drug, and he describes the need for an oral therapy and the company's commercial strategy now that the approval is in hand.

en-us

00:15:31

AI News: Singapore based Gero, a company focused on...

BiotechTV - News ·

2025/06/30

Co-Founder & CEO Peter Fedichev describes why he believes reading the amino acid sequences that have been written into the human genome over time is a more realistic way of discovering small molecules that will work rather than via protein-target structure models. He also discovers how the company is leveraging this for its focus on aging conditions and longevity.

en-us

00:13:55

Jones Research analyst Catherine Novack discusses...

BiotechTV - News ·

2025/06/27

She gives a scenario analysis in the event that FDA asked Capricor for more data rather than approving the therapy by its August 31st decision date. Plus, commentary on ProQR, Korro Bio, Wave, Crinetics, Dyne, Rezolute, Larimar, and Aldeyra.

en-us

00:20:31

ArsenalBio's Co-Founder & CEO Ken Drazan talks about...

BiotechTV - News ·

2025/06/27

He describes the ArsenalBio's "CITE" platform, which allows it to make heterogenous cells by inserting modifications all in the same place. Plus, writing in logic gating, harnessing shRNA, and more. The company recently raised a $325M series C.

en-us

00:17:28

Discussing hot button issues for biotech, and how...

BiotechTV - News ·

2025/06/27

He describes how some front and center issues for biotech either do or don't affect the M&A environment such as China, negative enterprise values, the FTC, valuations, the patent cliff, and more.

en-us

432 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter